Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Subjects aged from 20 to 64 years old (2)Subjects about 10 people with negative for specific IgE(RAST)against house dust and mite. (3)Subjects about 10 people with discomfort of eyes and nose(sneeze, runny nose, nasal) and positive for specific IgE (RAST) against house dust and mite.
Exclusion criteria
Exclusion criteria: (1)Subjects visiting the hospital for discomfort of eyes and nose or medicines affecting the test result (2)Subjects who have history of regular visits of otorhinolaryngology or planned to clinic visits (3)Subjects with acute rhinitis, sinusitis or hypertrophic rhinitis (4)Subjects with bronchial asthma (5)Subjects with allergies to the test food in the study (6)Subjects judged as unsuitable for the study by the investigator for laboratory evidence or cardiopulmonary function (7)Subjects who have a disease requiring regular medication or a history of serious diseases for which medication was required (8)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (9)Subjects who have participated in other clinical studies (10)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating (11)Subjects who are judges as unsuitable for the study based on the results of lifestyle questionnaire (12)Subjects who are judged as unsuitable for the study by the investigator for other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematologic test Blood biochemistry test Urine analysis Blood pressure/pulsation Weight/ body mass index Doctor's questions Adverse event Evaluate at points of 2 week and 4 week of ingestion and 2 weeks after the end of ingestion period | — |
Countries
Japan
Contacts
TTC Co., Ltd. Clinical Research Planning Department